Advance toward early diagnosis of chronic obstructive pulmonary disease

Chronic Obstructive Pulmonary Disease
Researchers have identified a "biomarker" that could lead to early detection of chronic obstructive pulmonary disease. Credit: National Heart Lung and Blood Institute

Researchers in Finland are reporting identification of the first potential "biomarker" that could be used in development of a sputum test for early detection of chronic obstructive pulmonary disease (COPD). That condition, which causes severe difficulty in breathing — most often in cigarette smokers — affects 12 million people in the United States.

In an article scheduled for the December 5 issue of ACS' Journal of Proteome Research, a monthly publication, Vuokko L. Kinnula and colleagues point out that no disease marker for COPD currently exists, despite extensive efforts by scientists to find one. Past research pointed to a prime candidate — surfactant protein A (SP-A), which has a major role in fighting infections and inflammation in the lung.

The scientists compared levels of a variety of proteins obtained from the lung tissues of healthy individuals, patients with COPD, and those with pulmonary fibrosis. They found that the lungs of COPD patients contained elevated levels of SP-A. The scientists also found elevated levels of SP-A in the sputum samples of COPD patients. "This suggests that SP-A might represent a helpful biomarker in the early detection of COPD and other related disorders," the article notes.

Article: "Proteomics of Human Lung Tissue Identifies Surfactant Protein A as a Marker of Chronic Obstructive Pulmonary Disease", pubs.acs.org/stoken/presspac/p … ll/10.1021/nl801495p

Source: ACS

Citation: Advance toward early diagnosis of chronic obstructive pulmonary disease (2008, December 8) retrieved 28 March 2024 from https://medicalxpress.com/news/2008-12-advance-early-diagnosis-chronic-obstructive.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

COPD set to reach about 600 million cases worldwide by 2050

 shares

Feedback to editors